Surgeons have performed the world’s second genetically modified pig heart transplant.
The team from the University of Maryland School of Medicine (UMSOM) successfully performed the procedure on a 58-year-old American father of two, Lawrence Faucette, who had reached the end stage of heart disease.
Traditional human heart transplants were ruled out due to pre-existing peripheral vascular disease and complications related to internal bleeding, making the pig heart transplant his only hope for survival.
Nullam et interdum sapien, eu facilisis erat. Etiam eget quam nisi. Integer imperdiet eros vel lorem pellentesque, non ornare libero aliquam. Phasellus nec urna molestie, pellentesque nisi at, volutpat odio. Mauris pulvinar efficitur neque at pretium. Nunc euismod turpis ante, et porttitor diam auctor sed. Ut erat metus, tincidunt a malesuada nec, blandit ut felis. Nullam pulvinar ac dolor at euismod. Curabitur scelerisque ac urna in cursus. Nulla nisi elit, consectetur a sem ac, laoreet condimentum massa